Endpoints News 生物医药· Lei Lei Wu·· 2026-10-05AI 评分45
Vaxcyte肺炎球菌疫苗VAX-31三期试验成功,股价单日上涨35%
Vaxcyte's pneumococcal vaccine succeeds in Phase 3, stock surges
AI 导读
Vaxcyte宣布其实验性肺炎球菌疫苗VAX-31在三期临床试验中达到关键终点。受此消息影响,该公司股票代码PCVX周一早盘股价上涨35%。
正文
Vaxcyte’s shares $PCVX jumped 35% Monday morning after the company announced that its experimental pneumococcal vaccine VAX-31 met its key endpoints in a Phase 3 …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news